U.S. Colonic Stents Market by Product Type (Nitinol Self Expandable Metal Stents (SEMS) and Elgiloy (Self Expandable Metal Stents (SEMS)), Indication (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders and Others), and End User (Hospitals and Specialty Clinics): Opportunity Analysis and Industry Forecast, 2018–2026
The U.S. colonic stents market was valued at $6.44 million in 2018 and is projected to reach $9.41 million by 2026, registering a CAGR of 4.8% from 2019 to 2026. A colonic stent is used to relieve acute colonic obstruction in colorectal cancer patients. The stent is compressed tightly onto a small delivery wire that allows the stent to be positioned across the tight narrowing to relieve blockage in the colon. Once opened, it relieves the obstruction by keeping the colon open that can take up to 24 hours for the stent to fully open. However, stents can be used when there is either a partial or complete blockage in the bowel to reduce the pressure in the bowel and relieve the obstruction. Further, stents are also used when surgery is not recommended as an alternative to keep the bowel working. It is usually performed by specialist doctors including endoscopist or by an interventional radiologist in the X-ray department.
Significant rise in incidences of colorectal cancer and benign strictures in the U.S are the major factors driving the U.S. colonic stents market. In addition, increase in demand for minimally invasive procedures and technological advancements regarding the development of more compatible metallic stents further propels the market growth of colonic stents in the near future. However, complications and high costs associated with colonic stents is anticipated to hamper the growth of the colonic stents market in the U.S. Moreover, colonic stenting improves the primary anastomosis rate with a low stoma creation in comparison with emergency surgery. Improved colonic stent such as self-expandable metallic stents (SEMS) is used for the bridge to surgery and it also able to cure patients with the palliative intent with advanced neoplastic disease, to avoid stoma and health care costs related to stoma. This provides a lucrative opportunity for the growth of the U.S. colonic stents market.
The report covers the U.S. colonic stents market forecast and analysis based on three categories that include product type, indication, and end user. Based on product type, the market is categorized into nitinol self-expandable metal stents, and elgiloy self-expandable metal stents. On the basis of indication, it is categorized into colorectal cancer, colonic benign strictures and others. By end user, the market is bifurcated into hospitals and specialty clinics.
KEY BENEFITS FOR STAKEHOLDERS
Key Market Segments
By Product Type
Self-Expandable Metal Stents
Significant rise in incidences of colorectal cancer and benign strictures in the U.S are the major factors driving the U.S. colonic stents market. In addition, increase in demand for minimally invasive procedures and technological advancements regarding the development of more compatible metallic stents further propels the market growth of colonic stents in the near future. However, complications and high costs associated with colonic stents is anticipated to hamper the growth of the colonic stents market in the U.S. Moreover, colonic stenting improves the primary anastomosis rate with a low stoma creation in comparison with emergency surgery. Improved colonic stent such as self-expandable metallic stents (SEMS) is used for the bridge to surgery and it also able to cure patients with the palliative intent with advanced neoplastic disease, to avoid stoma and health care costs related to stoma. This provides a lucrative opportunity for the growth of the U.S. colonic stents market.
The report covers the U.S. colonic stents market forecast and analysis based on three categories that include product type, indication, and end user. Based on product type, the market is categorized into nitinol self-expandable metal stents, and elgiloy self-expandable metal stents. On the basis of indication, it is categorized into colorectal cancer, colonic benign strictures and others. By end user, the market is bifurcated into hospitals and specialty clinics.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current U.S. colonic stents market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Product Type
Self-Expandable Metal Stents
- Nitinol Stent
- Elgiloy
- Colorectal Cancer/Bridge to Surgery
- Benign Colonic Strictures
- Other Indications
- Hospitals
- Specialty Clinics
- Boston Scientific Corporation
- Cook Medical Inc
- Cook Medical Inc
- Taewoong
- MI-TECH
- Olympus Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis, 2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High incidence of colorectal cancer in the U.S.
3.5.1.2. Significant agreements and collaborations in the colonic stent industry
3.5.2. Restraint
3.5.2.1. Product recalls associated with colonic stents
3.5.3. Opportunity
3.5.3.1. Development of innovative smartphone applications
3.6. Pricing Analysis, 2018-2026
CHAPTER 4: U.S. COLONIC STENTS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Self-Expandable Metal Stents (SEMSs)
4.1.1.1. Market size and forecast
4.1.1.2. Nitinol Stent
4.1.1.2.1. Market size and forecast
4.1.1.3. Elgiloy stent
4.1.1.3.1. Market size and forecast
CHAPTER 5: U.S. COLONIC STENTS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Colorectal Cancer/Bridge to Surgery
5.2.1. Market size and forecast
5.3. Colonic benign strictures
5.3.1. Market size and forecast
5.4. Other Indications
5.4.1. Market size and forecast
CHAPTER 6: U.S. COLONIC STENTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.3. Specialty Clinics
6.3.1. Market size and forecast
CHAPTER 7: COMPANY PROFILES
7.1. BOSTON SCIENTIFIC CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. COOK MEDICAL INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. ELLA - CS, s.r.o. (ELLA-CS)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. TAEWOONG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. M.I. TECH
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Key strategic moves and developments
7.6. Olympus Corporation
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis, 2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High incidence of colorectal cancer in the U.S.
3.5.1.2. Significant agreements and collaborations in the colonic stent industry
3.5.2. Restraint
3.5.2.1. Product recalls associated with colonic stents
3.5.3. Opportunity
3.5.3.1. Development of innovative smartphone applications
3.6. Pricing Analysis, 2018-2026
CHAPTER 4: U.S. COLONIC STENTS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Self-Expandable Metal Stents (SEMSs)
4.1.1.1. Market size and forecast
4.1.1.2. Nitinol Stent
4.1.1.2.1. Market size and forecast
4.1.1.3. Elgiloy stent
4.1.1.3.1. Market size and forecast
CHAPTER 5: U.S. COLONIC STENTS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Colorectal Cancer/Bridge to Surgery
5.2.1. Market size and forecast
5.3. Colonic benign strictures
5.3.1. Market size and forecast
5.4. Other Indications
5.4.1. Market size and forecast
CHAPTER 6: U.S. COLONIC STENTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.3. Specialty Clinics
6.3.1. Market size and forecast
CHAPTER 7: COMPANY PROFILES
7.1. BOSTON SCIENTIFIC CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. COOK MEDICAL INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. ELLA - CS, s.r.o. (ELLA-CS)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. TAEWOONG
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. M.I. TECH
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Key strategic moves and developments
7.6. Olympus Corporation
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
LIST OF TABLES
TABLE 01. U.S. COLONIC STENTS MARKET FOR SELF-EXPANDABLE METAL STENTS (SEMS), BY TYPE, 2018-2026 ($MILLION)
TABLE 02. U.S. COLONIC STENTS MARKET, BY INDICATION 2018-2026 ($MILLION)
TABLE 03. U.S. COLONIC STENTS FOR COLORECTAL CANCER, 2018-2026 ($MILLION)
TABLE 04. U.S. COLONIC STENTS MARKET, BY END USER 2018-2026($MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 09. COOK MEDICAL: OPERATING SEGMENTS
TABLE 10. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 11. ELLA-CS: COMPANY SNAPSHOT
TABLE 12. ELLA-CS: OPERATING SEGMENTS
TABLE 13. ELLA-CS: PRODUCT TYPE PORTFOLIO
TABLE 14. TAEWOONG: COMPANY SNAPSHOT
TABLE 15. ELLA-CS: OPERATING SEGMENTS
TABLE 16. TAEWOONG: PRODUCT TYPE PORTFOLIO
TABLE 17. M.I. TECH: COMPANY SNAPSHOT
TABLE 18. M.I. TECH: OPERATING SEGMENTS
TABLE 19. M.I. TECH: PRODUCT PORTFOLIO
TABLE 20. OLYMPUS: COMPANY SNAPSHOT
TABLE 21. OLYMPUS: OPERATING SEGMENTS
TABLE 22. OLYMPUS: PRODUCT PORTFOLIO
TABLE 01. U.S. COLONIC STENTS MARKET FOR SELF-EXPANDABLE METAL STENTS (SEMS), BY TYPE, 2018-2026 ($MILLION)
TABLE 02. U.S. COLONIC STENTS MARKET, BY INDICATION 2018-2026 ($MILLION)
TABLE 03. U.S. COLONIC STENTS FOR COLORECTAL CANCER, 2018-2026 ($MILLION)
TABLE 04. U.S. COLONIC STENTS MARKET, BY END USER 2018-2026($MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 09. COOK MEDICAL: OPERATING SEGMENTS
TABLE 10. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 11. ELLA-CS: COMPANY SNAPSHOT
TABLE 12. ELLA-CS: OPERATING SEGMENTS
TABLE 13. ELLA-CS: PRODUCT TYPE PORTFOLIO
TABLE 14. TAEWOONG: COMPANY SNAPSHOT
TABLE 15. ELLA-CS: OPERATING SEGMENTS
TABLE 16. TAEWOONG: PRODUCT TYPE PORTFOLIO
TABLE 17. M.I. TECH: COMPANY SNAPSHOT
TABLE 18. M.I. TECH: OPERATING SEGMENTS
TABLE 19. M.I. TECH: PRODUCT PORTFOLIO
TABLE 20. OLYMPUS: COMPANY SNAPSHOT
TABLE 21. OLYMPUS: OPERATING SEGMENTS
TABLE 22. OLYMPUS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. U.S. COLONICS STENTS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. LOW BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. HIGH COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2018
FIGURE 09. MARKET DRIVERS, RESTRAINT, AND OPPORTUNITY
FIGURE 10. PRICING ANALYSIS OF ENTERAL FEEDING PUMPS, BY REGION, 2018
FIGURE 11. U.S. COLONIC STENTS FOR NITINOL STENT, 2018-2026 ($MILLION)
FIGURE 12. U.S. COLONIC STENTS MARKET FOR ELGILOY STENT, 2018-2026 ($MILLION)
FIGURE 13. U.S. COLONIC STENTS FOR COLONIC BENIGN STRICTURES, 2018-2026 ($MILLION)
FIGURE 14. U.S. COLONIC STENTS FOR OTHER INDICATIONS, 2018-2026 ($MILLION)
FIGURE 15. U.S. COLONIC STENTS FOR HOSPITALS, 2018-2026 ($MILLION)
FIGURE 16. U.S. COLONIC STENTS FOR SPECIALTY CLINICS, 2018-2026 ($MILLION)
FIGURE 17. BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2018 (%)
FIGURE 19. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2018 (%)
FIGURE 20. OLYMPUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. OLYMPUS: NET SALES, BY SEGMENT, 2018 (%)
FIGURE 22. OLYMPUS: NET SALES, BY REGION, 2018 (%)
FIGURE 01. U.S. COLONICS STENTS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. LOW BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. HIGH COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2018
FIGURE 09. MARKET DRIVERS, RESTRAINT, AND OPPORTUNITY
FIGURE 10. PRICING ANALYSIS OF ENTERAL FEEDING PUMPS, BY REGION, 2018
FIGURE 11. U.S. COLONIC STENTS FOR NITINOL STENT, 2018-2026 ($MILLION)
FIGURE 12. U.S. COLONIC STENTS MARKET FOR ELGILOY STENT, 2018-2026 ($MILLION)
FIGURE 13. U.S. COLONIC STENTS FOR COLONIC BENIGN STRICTURES, 2018-2026 ($MILLION)
FIGURE 14. U.S. COLONIC STENTS FOR OTHER INDICATIONS, 2018-2026 ($MILLION)
FIGURE 15. U.S. COLONIC STENTS FOR HOSPITALS, 2018-2026 ($MILLION)
FIGURE 16. U.S. COLONIC STENTS FOR SPECIALTY CLINICS, 2018-2026 ($MILLION)
FIGURE 17. BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2018 (%)
FIGURE 19. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2018 (%)
FIGURE 20. OLYMPUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. OLYMPUS: NET SALES, BY SEGMENT, 2018 (%)
FIGURE 22. OLYMPUS: NET SALES, BY REGION, 2018 (%)
